City of Mississauga Applauds Roche Canada Jobs Investment in Life Sciences Industry

Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. " Mississaugawas selected for this investment based on a strong competitive business environment, exceptional talent...

Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.

"Mississauga was selected for this investment based on a strong competitive business environment, exceptional talent pool, and a government committed to fostering growth in the sector," says Ronnie Miller, President and CEO of Roche Pharmaceuticals, Canada. "We applaud the hard work done by the Government of Ontario and the Premier's Office to foster a business environment that can compete internationally to attract investment opportunities, and Roche's commitment to add up to 500 specialized positions is a direct result of these positive changes. Without the support of all three levels of government, the Mississauga Board of Trade, Life Sciences Ontario, and Invest in Canada, who are all active advocates for a thriving sector, this investment would not have been possible."

Mississauga is the second largest Life Sciences Sector in Canada by employment, with more than 470 companies employing over 25,000 people.

"Mississauga is the first Canadian municipality to have a five year Life Sciences Cluster Strategy and Action Plan that focuses on establishing Mississauga as the premier Canadian destination for the commercialization of life sciences products, technologies and services," said Bonnie Brown, Director of Economic Development. "Our commitment to growing Mississauga's Life Sciences cluster has been instrumental in helping us achieve our economic goals and attracting new investment."

Roche Canada states the investment will create new and exciting employment opportunities, in particular for recent graduates of Ontario's strong science, technology, engineering and math academic institutions who will have the opportunity to impact the development of Roche's medicines from early stages through to patient use around the world.

For more information about Mississauga's Life Sciences Cluster, visit thefutureisunlimited.ca.

Photo - https://mma.prnewswire.com/media/1314877/City_of_Mississauga_City_of_Mississauga_Applauds_Roche_Canada_Jo.jpg  

Media Contact: Carley Smith, Supervisor, Media and Public Information, City of Mississauga, 905-615-3200, ext. 4203, [email protected], TTY: 905-896-5151